Biogen's Spinraza, the list price of which drops to $375,000 a year after the first year, was the first approved treatment for spinal muscular atrophy (SMA), a leading genetic cause of infant death, and was dominant until Zolgensma's entry last year. Zolgensma is the world's most expensive
I know that drug companies put a lot of time and money into research and development for new drugs. It usually takes them 10 years and about 1 billion dollars. But then, the (FDA) food and drug administration might not approve the drug for use. But come on now. Two million for a drug ? I used to work for a pharmaceutical company from 2012 to late 2015. Pharmaceutical companies have ads all over tv about their drugs. They spend more money on advertising, than on drug research. And still have loads of money besides. Or don't get sick.
Ok, I'm done with my rant.